Who Really Owns the Money Behind Your Annuity?

The point: your premium, someone else's baseball team

Here's a story that sounds too on-the-nose to be real. When an Arkansas woman named Clarice Whitmore paid about $45,000 for an annuity from Security Benefit Life in 2012, the money that company raised helped fund the purchase of the Los Angeles Dodgers. Not a metaphor — according to a class action suit, the first investment Security Benefit made after Whitmore paid was a $35 million loan to the partnership buying the baseball team, followed by nearly $1 billion more later that year.

The reason that's not just a fun trivia fact: the man behind the annuity company and the man behind the baseball deal were the same person. Guggenheim CEO Mark Walter controlled Security Benefit, and he co-founded the partnership that bought the Dodgers alongside company president Todd Boehly. The pair tapped insurers they controlled for over half the $2.15 billion price tag. That's the whole story of private credit's risk in miniature — not just that the money went somewhere risky, but that it went to the people signing the checks.

At Delaware Life, restatements pushed affiliated investments from 3% of invested assets to 42%.

What actually happened

Guggenheim controlled four insurance companies. Between them, per the suit, they put $5.1 billion into debt issued by Guggenheim-linked companies and lent nearly $1 billion to Guggenheim's business associates — against a total reported surplus (the cushion insurers hold above their obligations) of just $2 billion. They also reinsured risk with each other and with a fifth insurer that behaved like an affiliate but wasn't labeled one, which flattered how financially strong they looked.

That original lawsuit fizzled — one of Whitmore's attorneys filed to dismiss it a day after it was filed. But the pattern didn't go away. Earlier this year, two Guggenheim-linked insurers, Delaware Life and Clear Spring Life, got grand jury subpoenas over whether certain private credit investments should have been treated as related-party deals. Going back through their books, they found $22 billion in private credit that hadn't been properly disclosed to regulators as flowing to borrowers ultimately linked to Guggenheim. At Delaware Life, that pushed affiliated investments from a reported 3% of invested assets to 42%.

Walter says there's no victim. He's presented a cleanup plan to the Delaware Department of Insurance, already swapped $6.5 billion of Delaware Life's related-party investments for independent assets, agreed to sell his majority stake in the LA Lakers, and is in talks to offload his stake in Chelsea FC.

Why it matters

Insurance companies are supposed to be the boring, safe end of finance. You hand over money now, they promise to pay you decades later, and a regulator checks that they can. The whole system leans on arm's-length investing — the insurer lends to strangers, so it has every incentive to demand fair terms and honest pricing.

Related-party lending breaks that incentive. When the insurer, the borrower, and the guy at the top are all the same shop, there's no one on the other side of the table pushing back. Prices can be soft, disclosures can be thin, and the reinsurance can be circular — insurers passing risk to each other so everyone's balance sheet looks tougher than the underlying reality. A 3%-to-42% restatement isn't a rounding error; it's the difference between 'diversified and independent' and 'a captive funding machine.'

For a regular investor, the takeaway is uncomfortably practical. The brand on your annuity or life policy might be a thin wrapper around an asset manager using your long-term, illiquid premiums to fund its own bets. The safety you're paying for depends on plumbing you can't see.

The bigger picture

Guggenheim is the vivid example, but the author's point is it isn't the isolated one. Affiliated investments have been climbing across the industry as private credit — the fast-growing business of non-bank lending — buys deeper into insurance. Insurers offer something private credit firms love: a huge, sticky pool of long-term capital they can deploy into their own loans. Guggenheim is just, in the writer's phrase, 'the sharp edge of a much broader pattern.' The source notes strains at Blue Owl earlier in the year rattled the same nerves.

What to watch: whether the investigation widens beyond Guggenheim, whether regulators tighten what counts as a 'related party' (the definitions are exactly where the $22 billion hid), and whether other insurer-backed private credit shops quietly restate their own affiliated exposures. The concentration risk here isn't abstract — it's about who controls the capital, and whether they answer to you or to themselves. When the same name shows up on both the loan and the lender, that's your cue to read the footnotes.